ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2133

Simulation of Cartilage Damage in Osteoarthritis Using Patient-Derived Induced Pluripotent Stem Cells

Seung Min Jung1, Yoojun Nam2, Yeri Alice Rim2, Yong-Beom Park1, Seung-Ki Kwok3, Sung-Hwan Park4 and Ji Hyeon Ju5, 1Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, The Republic of, 3[email protected], Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 4Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 5Division of Rheumatology, Department of Internal Medicine,, College of Medicine, The Catholic University of Korea, Seoul, South Korea

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: cartilage, Osteoarthritis, pathogenesis and stem cells

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Biology and Pathology of Bone and Joint - Poster I

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) is a degenerative joint disease, leading to pain and functional limitation. Although OA is a most common form of musculoskeletal disease, the pathogenesis still remains to be determined. This study was aimed to investigate the characteristics of cartilage derived from OA-iPSCs. 

Methods: Dermal fibroblasts were obtained from one patient with early onset OA (age=31) and a healthy sibling without OA under informed consent. OA-iPSCs and control-iPSCs were reprogrammed from dermal fibroblasts, and differentiated into chondrocytes using outgrowth cells extending from embryoid bodies. The expression of cartilage specific markers was determined by immunohistochemical staining and reverse transcription-polymerase chain reaction (RT-PCR). To simulate the inflammatory condition of OA, chondrocytes differentiated from iPSCs were cultured in the presence of interleukin-1α.

Results: Dermal fibroblasts of OA patient and a healthy sibling were successfully reprogrammed into iPSCs. Pluripotency of OA-iPSCs and control-iPSCs was confirmed by immunohistochemical staining and RT-PCR for Nanog, Oct4, Fox2, and other pluripotent markers. All iPSCs were efficiently differentiated into cartilaginous pellet, which exhibit the chondrocyte-specific markers. Cartilage from OA-iPSCs showed an impaired mechanical integrity with porous structures. The expression of collagen type II were significantly decreased in OA-iPSC-cartilage, compared to control-iPSC-cartilage. Treatment of IL-1α enhanced the loss of cartilage, and the expression of matrix metalloproteinases and inflammatory molecules, in OA-iPSC-cartilage.

Conclusion: This study presented the impaired function of cartilage differentiated from OA patient derived iPSCs, and the simulation of cartilage damage in inflammatory condition of OA. Disease modeling of OA using patient-derived iPSCs would provide the better understanding for OA pathogenesis.


Disclosure: S. M. Jung, None; Y. Nam, None; Y. A. Rim, None; Y. B. Park, None; S. K. Kwok, None; S. H. Park, None; J. H. Ju, None.

To cite this abstract in AMA style:

Jung SM, Nam Y, Rim YA, Park YB, Kwok SK, Park SH, Ju JH. Simulation of Cartilage Damage in Osteoarthritis Using Patient-Derived Induced Pluripotent Stem Cells [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/simulation-of-cartilage-damage-in-osteoarthritis-using-patient-derived-induced-pluripotent-stem-cells/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/simulation-of-cartilage-damage-in-osteoarthritis-using-patient-derived-induced-pluripotent-stem-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology